Back to feed
Tirliedea: Russian Obesity Drug Cheaper Than Analogues

Tirliedea: Russian Obesity Drug Cheaper Than Analogues

The Russian obesity drug Tirliedea has surprised an academician of the Russian Academy of Sciences with its price. At a RBC roundtable, endocrinologist Gagik Galstyan stated that there are no analogs in the world: the domestic Tirliedea is more than twice as cheap as competitors in some dosages.

According to the doctor, modern therapy is currently received by less than two hundred diabetes patients, although many more people need it. The main problem is the cost of long-term treatment. According to the manufacturer, almost 250,000 people have already chosen Tirliedea in just two months.

Obesity treatment is gradually becoming less of a luxury

  • The drug is accessible to a wide range of patients due to its low price
  • Demand for treatment is growing among millions of Russians
  • The absence of global analogs makes the medicine unique
32.3K views

More from this channel Chyo po trendam

Similar in this category Technology